Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (3,735)	$ (4,829)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of debt discount and issuance cost	931	1,097
Bad debt expense	(126)	8
Gain on settlement of liabilities		(856)
Changes in deferred tax assets and liabilities	906	(719)
Change in allowance for sales returns and volume rebates	1,062	191
Change in inventory reserve	1,222	749
Change in fair value of derivative liabilities	40	(1,650)
Stock compensation expense	1,152	2,062
Depreciation and amortization	4,561	4,587
Change in right of use assets and lease liabilities	172	(98)
Changes in operating assets and liabilities:
Accounts receivable - trade	(6,953)	(13,839)
Inventories	20,076	2,010
Prepaid expenses and other current assets	(2,842)	(1,149)
Accounts payable and accrued expenses	(16,202)	2,969
Other liabilities	459	9
Deferred revenues	(713)	2,582
Net cash provided by (used in) operating activities	10	(6,876)
Cash flows from investing activities:
Purchases of furniture and fixtures, net	(100)	(659)
Net cash used in investing activities	(100)	(659)
Cash flows from financing activities:
Proceeds from short-term debt	3,000
Proceeds from long term debt		2,500
Principal payments on debt	(1,378)	(1,305)
Payments of fixed dividends to Series B Preferred stockholders	(635)	(631)
Proceeds from the exercise of options and warrants	13	57
Net cash provided by financing activities	1,000	621
Effect of foreign currency exchange rates	87	596
Net increase (decrease) in cash and cash equivalents	997	(6,318)
Cash and cash equivalents, beginning of the period	14,591	17,938
Cash and cash equivalents, end of the period	15,588	11,620
Supplemental cash flow disclosures:
Cash paid for income taxes	892	215
Cash paid for interest	4,050	$ 3,731
Non-cash investing and financing transactions:
Addition of right of use assets	$ 43